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Abstract 31
Dynamic changes in chromatin accessibility coincide with important aspects of neuronal differentiation, such as 32 fate specification and arealization and confer cell type-specific associations to neurodevelopmental disorders. 33 However, studies of the epigenomic landscape of the developing human brain have yet to be performed at single-34 cell resolution. Here, we profiled chromatin accessibility of >75,000 cells from eight distinct areas of developing 35 human forebrain using single cell ATAC-seq (scATACseq). We identified thousands of loci that undergo 36 extensive cell type-specific changes in accessibility during corticogenesis. Chromatin state profiling also reveals 37 novel distinctions between neural progenitor cells from different cortical areas not seen in transcriptomic profiles 38 and suggests a role for retinoic acid signaling in cortical arealization. Comparison of the cell type-specific 39 chromatin landscape of cerebral organoids to primary developing cortex found that organoids establish broad 40 cell type-specific enhancer accessibility patterns similar to the developing cortex, but lack many putative 41 regulatory elements identified in homologous primary cell types. Together, our results reveal the important 42 contribution of chromatin state to the emerging patterns of cell type diversity and cell fate specification and 43 provide a blueprint for evaluating the fidelity and robustness of cerebral organoids as a model for cortical 44 development. 45 46
Main text 47
The diverse cell types of the human cerebral cortex ( Fig. 1a ) have been mostly classified based on a handful of 48 morphological, anatomical, and physiological features. Recent innovations in single cell genomics, such as single 49 cell mRNA sequencing (scRNA-seq), have enabled massively parallel profiling of thousands of molecular 50 features in every cell, uncovering the remarkable molecular diversity of cell types previously considered 51 homologous, such as excitatory neurons located in different areas of the cerebral cortex 1-6 . However, the 52 developmental mechanisms underlying the emergence of distinct cellular identities are largely unknown, as most 53 cortical neurons are generated at stages that are inaccessible to experimentation 5 . 54 55
Over 60 years ago, Conrad Waddington introduced the concept of an epigenomic landscape to account for the 56 emergence of distinct cell fates 7 . In particular, chromatin state defines the functional architecture of the genome 57 by modulating the accessibility of gene regulatory elements, such as enhancers, which serve as binding sites for 58 transcriptional regulators. Together with the expression of unique combinations of transcription factors, 59 chromatin state is believed to represent the cis-regulatory 'vocabulary' of gene expression, which is a 60 fundamental determinant of cell identity 8, 9 . However, studies of chromatin state in the developing brain have 61 been largely limited as established methods for discovering gene regulatory elements, such as the assay for 62 transposase-accessible chromatin using sequencing 10 (ATACseq) or chromatin immunoprecipitation followed by 63 sequencing 11 (ChIP-seq), lacked cellular resolution and mainly focused on studies that enrich for broad cell 64 classes revealing changes in regional patterning and neuronal differentiation 8,12-17 . Several methods have been 65 recently developed to enable profiling of the epigenomic landscape at single cell resolution, such as scATAC-66 seq 18, 19 , revealing many cell type-specific patterns of enhancer activity in the developing and adult mouse brain, 67
as well as the adult human brain [20] [21] [22] . However, it is particularly important to characterize gene regulatory 68 elements in their native context of the developing human tissue, as growing evidence has shown that genetic 69 variants associated with psychiatric disease reside in evolutionary accelerated sequences that are putative 70 neurodevelopmental enhancers [23] [24] [25] [26] . 71 72
Chromatin states define the major cell types in the developing brain 73 To characterize the chromatin state landscape of the developing human brain at single cell resolution, we 74 performed scATACseq on primary samples of the human forebrain at midgestation (n = 6 individuals). For a 75 subset of samples, we preserved the anatomical region of origin information (Extended Data Table 1) , including 76 dorsolateral prefrontal cortex (PFC), primary visual cortex (V1), primary motor cortex (M1), primary 77 somatosensory cortex, dorso-lateral parietal cortex, temporal cortex, insular cortex, and the medial ganglionic 78 eminence (MGE), a major source of cortical interneurons 27,28 ( Fig. 1b , Extended Data Table 1 ). 79 80 We generated data from 77,354 cells passing quality control criteria (Methods, Extended Data Fig. 1a-d) . To 81 reduce the dimensionality of the dataset, we performed latent semantic indexing followed by singular value 82 decomposition (Methods). Batch correction was performed using the deep neural network-based scAlign 29 to 83 correct for technical sources of variance, including individual variation and processing method (Extended Data 84 Fig. 1e -f, Methods). We identified 25 distinct clusters using the Leiden community detection algorithm ( Fig. 1c , 85
Extended Data Fig. 1g-h ). This analysis robustly separated cortical and subcortical cells (MGE)( Fig. 1d ). 86 87
Next, to determine which epigenomic signatures correspond to the known cell types of the developing cortex, 88
we calculated 'gene activity scores' by summing fragments in the gene body and promoter regions, which 89
represents a proxy for gene expression 20,30 ( Fig. 1e ). Activity of canonical marker genes identified the major cell 90 classes, including radial glia (RG), intermediate progenitor cells (IPCs), excitatory neurons (ENs), and 91 interneurons (INs)( Fig. 1g , Extended Data Fig. 2a -b). To systematically predict cell identity, we correlated gene 92 activity scores from scATACseq cells with cell type marker genes inferred from previously published scRNAseq 93 data 1 (Methods), and assigned putative cell identity to every cell in the scATACseq dataset according to the 94 highest correlation of scRNAseq-based cluster ( Fig. 1f , Extended Data Fig. 2c ). Most scATACseq clusters had 95
one-to-one mapping to scRNAseq clusters, with few exceptions. Radial glia formed a single cluster in 96 scATACseq, but map to three scRNAseq clusters of radial glia ('ventricular', 'outer', and 'truncated'). Conversely, 97 many clusters of excitatory neurons mapped to a single cluster of PFC or V1 excitatory neurons from scRNAseq 98 ( Fig. 1h ). These discrepancies suggest that for some cell classes, epigenomic information may provide additional 99 resolution of cell types beyond transcriptional definitions, while in other cases, transcriptomics may reveal more 00 subtypes. 01 02
Single cell chromatin state profiling reveals candidate cell type specific enhancers 03
To identify putative cell type specific gene regulatory elements, we called peaks on aggregate single cells from 04 each cluster 31 (Methods, Fig. 1b ). Non-overlapping peaks were subsequently merged to a total union set of 05 398,139 peaks. Cluster-specific differentially accessible peaks were identified for each cluster, resulting in a set 06 of >200,000 DA peaks, with most clusters containing many thousands of cluster specific peaks (Fisher's Exact, 07
FDR<0.05, Fig. 1h , Extended Data Fig. 3 , Extended Data Fig. 4j ). Annotation of our peak set in genomic features 08
shows enrichment in intronic and distal intergenic regions and in the flanking regions of transcription start sites, 09
suggesting an enrichment of gene regulatory elements, such as enhancers (Extended Data Fig. 4a-b ). We 10 intersected our scATACseq peaks with publicly available ChIP-seq data for H3K27ac (GEO: GSE63648), a 11 marker for active enhancers, generated for comparable tissue samples, and found significant overlap with our 12 peaks (Permutation test, one-sided, p<0.001, Extended Data Fig. 4c ). We also intersected our peak set with a 13 set of validated forebrain enhancers 32 (VISTA Enhancer Browser) and found that 297/317 overlapped with our 14 peakset (Extended Data Fig. 4d ). Due to growing evidence that regions of the genome that have undergone 15 accelerated sequence evolution in humans are enriched for neurodevelopmental enhancers 24 , we intersected 16 our peak set with a set of 2,540 non-coding human accelerated regions (ncHARs) finding 880 overlaps (Extended 17 Data Fig. 4e ). Interestingly, chromatin accessibility profiles of MGE progenitors and MGE-derived cortical  18  interneurons were enriched for accessibility of ncHARs, and future studies are needed to elucidate if those  19 genomic changes could have contributed to the changes in interneuron repertoire across primates 33,34 ) 20
(Extended Data Fig. 4f -i). 21 22
To identify putative regulatory 'grammar' of cell types, we calculated enrichment of known transcription factor 23 binding motifs in cluster specific peak sets using HOMER 35 (Methods, Fig. 1h factor motif enrichments at the single cell level, we used ChromVAR, which estimates bias-corrected deviations 29 of transcription factor binding motif enrichments in scATAC-seq libraries, and found good agreement with top 30 motif enrichments for each cluster as determined by HOMER (Extended Data Fig. 4k ). Finally, we predicted 31 likely enhancers using the recently developed activity-by-contact (ABC) model 36 , which integrates H3K27ac 32
ChIP-seq, Hi-C, and gene expression data with chromatin accessibility to predict enhancers and link them to 33 their target genes (Methods). Using this method, we were able to identify sets of high-confidence putative 34 enhancers for each cell type and their likely target genes ( Fig. 1i ).
36
Vulnerability of cell type specific regulatory landscape to neurodevelopmental disorders 37
Mutations in non-coding genomic regions, as well as de novo loss of function mutations in chromatin regulators 38 have been implicated in a wide range of neurodevelopmental and psychiatric disorders, including schizophrenia 37 39 and autism spectrum disorder [38] [39] [40] [41] . However, due to the lack of cellular-resolution datasets of chromatin state 40 across developmental stages and differentiation states, these mutations cannot be tied to selective vulnerabilities 41 across diverse cell types of the developing human brain. To address this unmet need, we intersected cell type 42 specific ATAC-seq peaks with disease-linked common and rare non-coding variants (Methods). We first 43
intersected our cell type-specific peak sets with de novo non-coding mutations (DNMs) identified from ASD and 44 neurodevelopmental delay (NDD) cases and found significant enrichment of DNMs in 19 of 27 cell-type specific 45 peak sets, compared to a merged background peak set (Extended Data Figure 5 ). However, no cell type-specific 46 peak sets were significantly enriched for DNMs in probands compared to sibling controls. We also intersected 47 cell type specific peak sets with genomic regions enriched for copy number variants in cases with developmental 48 delay 42 , identifying cell types with significant enrichment and depletion ( Figure 1j ). Because such regions are 49 large and do not provide specificity with respect to individual genes, we next tested for enrichment of cell type 50 specific peaks in the flanking regions of genes associated with ASD and NDD and identified cell types with peak 51 sets significantly enriched and depleted in these regions ( Figure 1k ), but were underpowered to identify any 52 differences in the DNM burden in peaks within the promoter and gene body between probands and siblings 53 across peak sets. Finally, we sought to assess the enrichment of common variants associated with 54 neuropsychiatric disease risk in our cell type specific peak sets. To do this we performed a partitioned heritability 55 LD score regression analysis using summary statistics from large-scale genome-wide association studies of 56 schizophrenia, ASD, major depressive disorder, and bipolar disorder (Methods). For all four disorders, we 57 detected significant enrichments (FDR < 0.05) of risk-associated variants in peaks from at least one cell type. 58
Interestingly, we found that, consistently across disorders, disease risk was most strongly enriched in excitatory 59 neuron populations ( Figure 1l ). 60 61
Dynamic changes in chromatin accessibility during neuronal differentiation 62
Developing tissues pose unique challenges to single cell analysis methods because, unlike the adult tissue, 63 many cells represent developmentally transient states along the continuum of lineage progression. Chromatin 64 state profiling provides a unique opportunity to characterize the Waddingtonian landscape of cell fate decisions 65 underlying the emergence of cell types during development. Identification of putative regulatory mechanisms of 66 cell fate specification could in turn be harnessed to promote directed differentiation of molecularly-defined cell 67 types from pluripotent stem cells for applications in cell replacement therapy and disease modelling. To combine 68 transcriptomic and epigenomic information, we coembedded scRNAseq and scATACseq datasets generated in 69 parallel from samples of visual cortex ( Fig. 2a ). By projecting cluster annotations across the three comparisons 70 (scRNAseq only, scATACseq only, and multimodal mapping), we were able to further support our predictions of 71 cellular classification from chromatin state data ( Fig. 2b ). Projections of gene expression and gene activity scores 72 in the co-embedded space show that distinct clustering of unique cell types is preserved and that scATACseq 73 and scRNAseq cells of the same type cluster together ( Fig. 2c-d ). Because the ability to identify cell types across 74 samples, species, and experimental models using single cell genomics approaches depends on robust detection 75 of gene co-expression relationships 1,43 , we sought to compare gene-module assignments calculated based on 76
mRNA expression values detected using scRNAseq or those inferred from scATACseq. We combined genes 77 into modules using weighted gene co-expression network analysis 44 and compared eigengene projections as 78 well as gene-module assignments between scRNAseq and scATACseq datasets (Extended Data Fig. 6a-b ). 79
This analysis revealed a remarkable conservation of gene co-expression relationships, with the exception of 80 genes related to signaling pathway activation that formed co-expression module in scRNAseq but not 81 scATACseq datasets, and genes related to synapse assembly forming co-expression module in scATACseq, 82
but not scATACseq dataset (Extended Data Fig. 6d -g). Together, our joint analysis of scRNAseq and 83 scATACseq datasets further underscored the conserved representation of the major cell types and gene co-84 expression relationships across the two modalities. 85 86
To identify trajectories of chromatin accessibility underlying excitatory neuron differentiation and maturation, we 87 performed pseudotemporal ordering of cells in the co-embedded space 45 ( Fig. 2e , Methods). Consistent with the 88 known patterns of neurogenesis, pseudotime reconstruction ordered sequentially radial glia, intermediate 89 progenitors, and excitatory neurons. We identified hundreds of loci with sharp, transient accessibility across 90 pseudotime, and predicted enhancers that interact with genes linked to cell type identity ( Fig. 2f ,g). By calculating 91 transcription factor binding site enrichment across peaks that show dynamic changes in accessibility along 92 pseudotime, we reconstructed the known hierarchy of transcription factors involved in cortical neurogenesis, 93
including sequential enrichment for SOX2, ASCL1, and NEUROD2 binding sites among transiently accessible 94 loci (Extended Data Fig. 7) . These results challenge the prevailing model of differentiation as a transition between 95 two phases involving progressive loss of accessibility of sites open in progenitor cells and gradual opening of 96 sites relevant to postmitotic cells 46 , and underscore highly dynamic transient states of chromatin accessibility 97 during human cortical neurogenesis. 98 99
Furthermore, we leveraged the scRNAseq and scATACseq co-embedding to compare changes in gene 00 expression, enhancer accessibility, and transcription factor motif enrichment along the differentiation trajectory. 01
Considering a few key regulators of neurogenesis, SOX2, EOMES, and NEUROD2, we observed a trend for 02 accessibility of predicted enhancers to precede changes in gene expression ( Fig. 2h ). These findings are 03 consistent with recent reports 21,47 and support the model whereby changes in chromatin state along a 04 developmental lineage foreshadow changes in gene expression and cell fate decisions. Intersection of cell type 05 and developmentally dynamic loci and putative regulatory elements with whole genome sequencing data from 06 neurodevelopmental or neuropsychiatric disorders may reveal developmentally transient states that are 07 vulnerable to non-coding mutations. 08 09
Cortical progenitors develop area-specific chromatin states 10
Single cell transcriptomics recently revealed that area-specific cortical excitatory neurons emerge during early 11 neurogenesis, while only limited molecular differences can be found between progenitor cells 1,2 . Given that 12 changes in the accessibility of regulatory elements often precede changes in gene expression ( Fig. 2h ), we 13 sought to examine whether epigenomic signatures could foreshadow the emergence of area-specific excitatory 14
neurons. Specifically, we compared scRNAseq and scATACseq profiles of excitatory lineage cells sampled from 15 the extremes of the rostral-caudal axis, PFC and V1 ( Fig. 3a-b , Extended Data Fig. 8a -h). For each modality, we 16 ordered the cells in pseudotime to approximate the differentiation trajectory, and identified the 'branch' point 17 along this trajectory at which transcriptomic or chromatin state differences between PFC and V1 lineages 18 become apparent. In contrast to transcriptomic data, which only distinguishes maturing excitatory neuron clusters 19 from distinct cortical areas 1 (Fig. 3h ), chromatin state signatures reveal a striking divergence between PFC and 20 V1 earlier in differentiation, and define area-specific IPC populations ( Fig. 3g ). 21 22
To identify putative regulatory networks that could underlie the divergence of PFC and V1 lineages, we performed 23 transcription factor binding site enrichment analysis 35 on peaks that were differentially accessible between PFC 24 and V1 (Fisher's Exact, two-sided, FDR<0.05, Fig. 3i -l, Extended Data Figure 8i -j, Supplementary Tables 1&2).  25  This analysis recovered previously known regulators of cortical arealization and those consistent with  26  transcriptomic studies 1,48 . For example, our analysis predicts motif enrichment for known transcription factors  27  enriched in the PFC, including POU3F2, MEIS1, TBR1, NEUROD1, NEUROG2, and TBX21 (Supplementary  28  Table 1 ). Interestingly, many of the candidates identified in this analysis relate to retinoic acid signaling pathway. 29
In early development, retinoic acid signaling plays a well-established role in development of caudal fates, 30
including hindbrain and spinal cord 49 . However, at later stages of development, retinoic acid signaling has been 31
shown to interact with pathways involved in cortical arealization including the NR2F1 transcription factor and Wnt 32 signaling that promote occipital (visual cortex) identities 50,51 , and is negatively regulated by TGIF1 52 , the top 33 enriched motif among PFC cells ( Fig. 3j-k) . Together, our analyses suggest that epigenomic differences 34 distinguish cortical progenitor cells between cortical areas and foreshadow the emergence of area-specific 35 excitatory neuron subtypes. In addition, our study suggests a previously unappreciated role for the retinoic 36 signaling pathway in cortical arealization. 37 38
An epigenomic 'report card' for in vitro models of cortical neurogenesis 39
Due to the scarcity of primary human tissue, studies of human neural development critically require suitable in 40 vitro models. Cerebral organoids are a three-dimensional culture model of the developing brain that can be 41 derived from somatic cells. Previous studies emphasized the similarities between cerebral organoid cells and 42 their in vivo counterparts using single cell transcriptomics 43,53,54 and bulk epigenomics 15, 17 . We sought to extend 43 these comparisons by performing chromatin state profiling of cerebral organoids at single cell resolution and 44 generated scATACseq data for cortical organoids derived via directed differentiation from three genetically 45 normal individuals 43 ( Fig. 4a , Extended Data Fig. 9a , Methods). We identified the major classes of cell types 46 expected to emerge in this model, including radial glia, IPCs, interneurons, and excitatory neurons, although 47 individual clusters were less discrete than their in vivo counterparts, and contained fewer distinguishing 48 chromatin state features ( Fig. 4b-d , Extended Data Fig. 9d ,f). 49 50
To compare organoid clusters with their primary counterparts, we quantified the chromatin accessibility signal 51 from organoid cells in peaks defined from primary cells, allowing us to identify clusters representing homologous 52 cell types (Methods, Fig. 4e ). We found that cell type specific peaks identified in primary cells maintained cell 53 type specificity in organoid cells, but many peaks corresponding to cell types not present in organoids, such as 54 microglia and endothelial cells, were missing ( Fig. 4g , Extended Data Fig. 9e ). Next, to assess the fidelity of 55 organoids as a model for the epigenomic state of primary cortical cells, we called peaks for each organoid cluster 56 and compared with primary peaks for homologous cell types. We found that, while organoids mostly contain 57 peaks found in their corresponding primary counterparts, they are missing ~50% of peaks identified in primary 58 clusters ( Fig. 4f , Extended Data Fig. 9b -c). Interestingly, shared peaks show higher enrichment in promoter 59 regions, while peaks found only in primary are more enriched in distal intergenic and intronic regions, suggesting 60 that organoids may be missing many distal regulatory elements identified in primary cells. In addition, we 61 compared enhancers predicted by activity-by-contact model, which revealed that organoids lack many candidate 62 cell type specific enhancers found in primary, even after correcting for cellular coverage (Fig. 4h ). 63 64
In summary, scATACseq data generated for primary cells represents a blueprint for normal epigenomic states 65 of cell types in the developing human brain that serves as a reverence for evaluating the fidelity and robustness 66 of in vitro derived models. Our analysis reveals features of chromatin state found in normal developing brain are 67 recapitulated in cerebral organoids, epigenomic features of organoid cell types are less discrete and lack 68 thousands of distal regulatory elements found in vivo. 69 70
Discussion 71
By performing massively parallel single cell profiling of chromatin state, we were able to extend previous studies 72 of cell-type specific epigenomic regulation of brain development. Specifically, scATAC-seq analyses reveals 73 transiently accessible loci that track with neuronal differentiation. These states may reveal mechanisms 74
governing the establishment of cell fate during neurogenesis, in particular those underlying the emergence of 75 area-specific excitatory neurons. Our findings provide new perspectives on the mechanisms underlying the 76 rewiring of regulatory pathways during neurogenesis 46 . Intersection of chromatin state landscape with disease 77 variants implicates post-mitotic, developing cortical excitatory neurons in the etiopathogenesis of 78 neuropsychiatric disorders 14,55,56 , and future studies are needed to probe how disease-associated variants in 79 these regulatory regions modify cell fate decisions in the developing cortex. Furthermore, our findings suggest a 80 potential limitation for cortical organoids to serve as experimental models to test these hypotheses, as many 81 non-coding regulatory elements, in particular distal enhancers, may not be recapitulated in this model. In order 82
to determine the fidelity of organoids as a model for the epigenomic landscape of the developing brain, functional 83 characterization of conserved and non-conserved chromatin features in vivo and in vitro will be required. In 84 addition to serving as a reference for evaluating in vitro models of human brain development, our data will enable 85 scalable prediction of candidate cell type specific regulatory elements that could facilitate the development of Competing Interests 95
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Brain . 4 : Cell type-specific differences in chromatin accessibility between cerebral organoids and the 08 developing human brain. a) Schematic depicting experimental workflow. PSCspluripotent stem cells. b) 09 UMAP projection of all organoid scATACseq cells (n = 3 organoids from different lines, 11,171 cells) colored by 10 leiden clusters. c) UMAP projections of gene activity scores for GFAP marking radial glia, EOMES marking 11 intermediate progenitors, DLX1 marking interneurons, and NEUROD2 marking excitatory neurons. d) UMAP 12 projection of all organoid scATACseq cells colored by cell type predictions (Methods). e) Heatmap of pearson 13 correlations between primary and organoid scATACseq clusters based on a common peak set. f) Top left, 14 overlap of primary and organoid radial glia peak sets. Iodixanol gradient for 20 minutes at 3000rcf at 4C in a swinging bucket centrifuge with the brake turned off. The 98 nuclei band was then carefully pipetted and nuclei were diluted in Wash Buffer. 99 00
Cortical organoid differentiation protocol 01
Cortical organoids were cultured using a forebrain directed differentiation protocol 2,3 . Briefly, 3 genetically normal 02 PSC lines, H28126, 1323-4, and H1 (WA01), were expanded and dissociated to single cells using accutase. 03
After dissociation, cells were reconstituted in neural induction media at a density of 10,000 cells per well in 96 04
well v-bottom low adhesion plates. GMEM-based neural induction media includes 20% Knockout Serum 05
Replacer (KSR), 1X non-essential amino acids, 0.11mg/mL Sodium Pyruvate, 1X Penicillin-Streptomycin, 0.1mM 06
Beta Mercaptoethanol, 5uM SB431542 and 3uM IWR1-endo. Media was supplemented with 20uM Rock inhibitor 07 Y-27632 for the first 6 days. After 18 days organoids were transferred from 96 to six well low adhesion plates 08 and moved to an orbital shaker rotating at 90rpm and changed to DMEM/F12-based media containing 1X 09
Glutamax, 1X N2, 1X CD Lipid Concentrate and 1X Penicillin-Streptomycin. At 35 days, organoids were moved 10 into DMEM/F12-based media containing 10% FBS, 5ug/mL Heparin, 1X N2, 1X CD Lipid Concentrate and 0.5% 11
Matrigel. Throughout culture duration organoids were fed every other day. 12 13
Nuclei isolation from cerebral organoids 14
Cerebral organoids were dissociated in Papain containing Deoxyribonuclease I (DNase) for 30 minutes at 37C 15 and samples were triturated to form a single cell suspension. 10 6 Cells were pelleted and lysed for 3 minutes in 16 100uL chilled Lysis Buffer (10mM Tris-HCl pH7.4, 10mM NaCl, 3mM MgCl2, 0.1% Tween-20, 0.1% Igepal CA-17 630, 0.01% Digitonin, 1% BSA). Lysed cells were then washed with 1mL chilled Wash Buffer (10mM Tris-HCl 18 pH7.4, 10mM NaCl, 3mM MgCl2, 0.1% Tween-20, 1% BSA) and nuclei were pelleted at 500rcf for 5 minutes at 19 4C. 20 21
Single Cell RNA-seq Library Preparation and Sequencing 22
Single cell RNA-seq libraries were generated using the 10x Genomics Chromium 3' Gene Expression Kit. Briefly, 23 single cells were loaded onto chromium chips with a capture target of 10,000 cells per sample. Libraries were 24 prepped following the provided protocol and sequenced on an Illumina NovaSeq with a targeted sequencing 25 depth of 50,000 reads per cell. BCL files from sequencing were then used as inputs to the 10X Genomics Cell 26
Ranger pipeline. 27 28
Single Cell RNA-seq Analysis 29
For preprocessing of scRNA-seq data, a minimum of 500 genes and 5% mitochondrial cutoff was used and 30
Scrublet 4 for doublet removal. The SCTransform 5 workflow in Seurat 6 were run separately on each batch. 31
Canonical component analysis (CCA) on the Pearson residuals from SCTransform was used as input into 32 scAlign for batch correction. 33 34
Bulk ATAC-seq Library Preparation and Sequencing 35
Bulk ATAC-seq libraries were generated using the protocol outlined in Corces MR et al., 2017 ( 1 ). Briefly, 50,000 36 nuclei were permeablized and tagmented. Tagmented chromatin libraries were generated and sequenced on an 37
Illumina NovaSeq with a target sequencing depth of 50 million reads per library. Sequencing data was used as 38 an input to the ENCODE ATAC-seq analysis pipeline (https://github.com/ENCODE-DCC/atac-seq-pipeline). 39 40
Single Cell ATAC-seq Library Preparation and Sequencing 41
Nuclei were prepared as outlined in the 10X Genomics Chromium single cell ATAC-seq solution protocol. Nuclei 42
were loaded with a capture target of 10,000 nuclei per sample. scATAC-seq libraries were prepared for 43 sequencing following the 10X Genomics single cell ATAC-seq solution protocol. scATAC-seq libraries were 44 sequenced using PE150 sequencing on an Illumina NovaSeq with a target depth of 25,000 reads per nucleus 45 (see Extended Data Table 1 ). 46 47
Single Cell ATAC-seq Analysis Pipeline 48
Cell Ranger 49 BCL files generated from sequencing were used as inputs to the 10X Genomics Cell Ranger ATAC pipeline. 50
Briefly, FASTQ files were generated and aligned to GRCh38 using BWA. Fragment files were generated 51 containing all unique properly paired and aligned fragments with MAPQ > 30. Each unique fragment is associated 52 with a single cell barcode. 53 54
SnapATAC 55
Fragment files generated from the Cell Ranger ATAC pipeline were loaded into the SnapATAC 7 pipeline 56 (https://github.com/r3fang/SnapATAC) and Snap files were generated. A cell-by-bin matrix was then generated 57 for each sample by segmenting the genome into 5-Kb windows and scoring each cell for reads in each window. 58
Cells were filtered based on log10(UMI) between 3-5 and fraction of reads in promoters between 10-60% to obtain 59 cells with high quality libraries. Bins were then filtered, removing bins overlapping ENCODE blacklist regions 60 (http://mitra.stanford.edu/kundaje/akundaje/release/blacklists/). This matrix was then binarized and coverage of 61 each bin was calculated and normalized by log10(count + 1). Z-scores were calculated from normalized bin 62 coverages and bins with a z-score beyond ± 2 were filtered from further analysis. A cell-by-cell similarity matrix 63 was generated by calculating the Latent Semantic Index (LSI) of the binarized bin matrix. Principal component 64 analysis (PCA) was then performed on LSI values. The top 50 principal components were used for batch 65 correction through scAlign. 66 67
scAlign Batch Correction 68
Multiple batches were integrated using the scAlign package 8 (https://github.com/quon-titative-biology/scAlign). 69
The ATAC batches were first merged together to calculate the Latent Semantic Index (LSI) with the TF matrix 70 log-scaled for input into PCA. The 50 principal components of LSI were used as inputs to the encoder. The latent 71
dimension was set at 32 and ran with all-pairs alignment of all batches. The input dimension to the encoder was 72 set to 50 to match the input 50 principal components, and trained to 15,000 iterations using the small architecture 73 setting with batch normalization (BN). The 32 dimensions were used for downstream analysis for finding 74 neighbors. The scRNAseq were processed using Seurat and computed the top 15 components from CCA for 75 input into scAlign, and the latent dimension was set to 20 using the small architecture with BN and 15,000 76
iterations. All alignments were unsupervised. 77 78
Clustering and Visualization 79
In order to visualize the high dimensionality dataset in 2D space, the latent dimensions for the ATAC and RNA 80
data from scAlign were used to construct UMAP (https://arxiv.org/abs/1802.03426) graphs from Seurat. A K-81 nearest neighbor graph was constructed using the latent dimensions from scAlign. The leiden algorithm was 82 then used to identify 'communities', or clusters, in the sample, representing groups of cells likely to be of the 83 same cell type. 84 85
Calculating Gene Activity Scores 86
To create a proxy for gene expression, ATACseq fragments in the gene-body plus promoter (2Kb upstream from 87 transcription start sites) of all protein-coding genes were summed for each cell to generate 'Gene Activity Scores'. 88
A matrix was constructed for all gene activity scores by all cells. Due to the sparsity of scATAC-seq data, the 89 MAGIC imputation method 9 was used to impute gene activity scores based on the K-nearest neighbor graph. 90 91
Cell Type Predictions 92
In order to link scATACseq clusters to known cell types of the developing cortex, gene activity scores were used 93 to correlate scATACseq cells with cell types from scRNAseq data generated from similar samples 10 . Briefly, 94
cluster 'marker genes' were identified for each leiden cluster by performing a Fisher's Exact test for enrichment 95 of gene activity scores. The top 300 enriched genes for each cluster were identified based on p-value. Similarly, 96
cell type marker genes were identified for annotated cell types from Nowakowski et al. 2017 10 , and the top 300 97 genes for each cluster were identified based on p-value. The intersection of genes from scATACseq marker 98 genes and scRNAseq marker genes was identified, resulting in a set of 1084 genes. Average expression values 99
for each scRNAseq cell type for each of the 1084 genes was determined. For each scATACseq cell, the gene 00 activity scores of the 1084 genes was correlated with cell type averages from the scRNAseq data and a cell type 01 prediction was made based on the cell type most highly correlated with each scATACseq cell. 02 03
Peak Calling 04
Fragments from cells were grouped together by cluster and peaks were called on all cluster fragments using 05 MACS2 (https://github.com/taoliu/MACS) with the parameters '--nomodel --shift -37 --ext 73 --qval 1e-2 -B --06 SPMR --call-summits'. Peaks from each cluster were then combined to form a master peak set and a cell-by-07 peak matrix was constructed. This matrix was binarized for all downstream applications. 08 09
Determination of Differentially Accessible Peaks 10
Differentially accessible peaks for each cluster were determined by performing a two-sided Fisher's exact test, 11
and selecting peaks that had log fold change >0, and FDR-corrected p-value < 0.05. 12 13
Visualizing Cluster Signal in Peaks 14
The deeptools suite 11 (https://deeptools.readthedocs.io/en/develop/) was used to visualize pileups of cluster-15 specific ATACseq signal (output from MACS2) in DA peak sets. 16 17
Transcription Factor Motif Enrichment Analysis 18
The findMotifsGenome.pl tool from the HOMER suite 12 (http://homer.ucsd.edu/homer/) was used to identify TF 19 motif enrichments in peak sets. The ChromVAR R package 13 was used to identify TF motif enrichments at the 20 single cell level in scATACseq data. Briefly, the peak-by-cell matrix from the snap object was used as an input, 21
filtering for peaks open in at least 10 cells. Biased-corrected TF motif deviations were calculated for the set of 22 1,764 human TF motifs for each cell. 23 24
Enhancer-Gene Predicted Interactions 25
The Activity-by-Contact (ABC) model 14 (https://github.com/broadinstitute/ABC-Enhancer-Gene-Prediction) was 26 used for prediction of enhancer-gene interactions from scATACseq data. Cluster-specific ATAC-seq signal and 27 peak outputs from MACS2 were used as inputs. Gene expression values from scRNAseq of GW20 visual cortex 28
were averaged and used an input. As recommended and provided by the creators of ABC, an averaged Hi-C 29 profile of 10 cell types was used as an input. 30 31
VISTA Enhancer Intersections 32 VISTA Enhancers were taken from the VISTA Enhancer Browser (https://enhancer.lbl.gov/) and filtered for 33
human sequences found to be active in the forebrain. Enhancers were lifted over to Hg38 using the UCSC 34
LiftOver tool (https://genome.ucsc.edu/cgi-bin/hgLiftOver) and overlapping regions were merged, resulting in 317 35 unique regions. These regions were intersected with the peak set from all primary scATACseq cells and 297 36 peaks overlapping VISTA forebrain enhancer regions were identified. 37 38
Non-coding Human Accelerated Region Intersections 39
Non-coding Human Accelerated Regions (ncHARs) were taken from Capra et al. 2013 15 . These regions were 40 then lifted over to Hg38 using the UCSC LiftOver tool and overlapping regions were merged, resulting in 2,540 41 unique regions. These regions were intersected with the peak set from all primary scATACseq cells and 880 42 peaks overlapping ncHAR regions were identified. 43 44
H3K27ac ChIP-seq Data Intersection 45
Publicly available H3K27ac ChIP-seq peak sets generated from 12pcw (GW14) human cortical samples 16 were 46 obtained from GEO (GEO: GSE63648 To anchor mRNA expression and chromatin state profiles in the same map of cell diversity, we applied scAlign 82 on datasets where we profiled scRNAseq and scATACseq in parallel in the sample sample. This was achieved 83 by linking gene expression data to gene activity scores derived from chromatin accessibility data. The gene 84 activity scores were logRPM values derived from gene activity scores generated by the SnapATAC pipeline. 85
Then the gene expression and gene activity scores were processed using Seurat, and then split into batches for 86 input into scAlign. The encoder space was computed using multi CCA of the 10 dimensions with latent 87 dimensions at 20 using the 'small' architecture. 88 89
Disease Intersection 90
De novo mutation (DNM) enrichment 91
Peak sets from 27 cell types were intersected DNMs from 2,708 probands and 1,876 siblings using bedtools 92 v2.24.0. Peak sets were determined based on the presence of the peak in at least 5% of the cells for that cell 93 type. DNMs were identified by an in-house pipeline. Briefly, variants from whole-genome sequencing data were 94 called using four independent callers: GATK v3.8, FreeBayes, Strelka, and Platypus. Variant calls from each 95 caller were intersected, and filtered for read depth (> 9), allele balance (> 0.25), absence of reads supporting the 96 mutation in parents, and identified by at least three of the four callers. 97 98
Peak sets were tested for an enrichment of DNMs in probands as compared to a background peak set which 99 contained all peaks. We used a Fisher's exact test to compare the number of peaks with one or more DNMs 00 between the cell type-specific peak set and the background peak set. We also performed a Wilcox rank sum test 01 comparing the number of DNMs per peak in the cell type-specific set to the background peak set. We applied a 02
Bonferroni multiple test correction for 27 tests (# of cell types) to all p-values. 03 04 ASD/NDD gene set enrichment 05
We created gene plus promoter regions using bedtools v2.24.0, where we defined the promoter as the 1Mb 06 region upstream of the gene transcription start sites. Gene regions were defined using Gencode V27. Peak sets 07
were determined based on the presence of the peak in at least 5% of the cells for that cell type. The total number 08 of peaks in each gene plus promoter region was quantified per gene for each cell type and compared to the 09 number of peaks in the merged peak set for each gene set using a Fisher's exact test. The peaks in the remaining 10 gene plus promoter regions were used as background. Gene sets from Coe et al. 22 (COE253), Kaplanis et al. 23 11 (DDD299) and SFARI gene (SFARI854) were used for enrichment testing. P-values were Bonferroni corrected 12 for 81 tests (27 cell types and 3 gene sets). In addition, we also compared the number of probands and siblings 13 carrying one or more DNMs in a peak within the gene plus promoter region of genes in the union set of the three 14 gene sets tested above. Burden was quantified using a Fisher's exact test for each peak set. P-values were 15
Bonferroni corrected for 28 tests (# of cell types plus the merged peak set). 16 17
Morbidity map CNV enrichment 18
CNVs enriched in NDD cases from Coe et al 2014 22 were intersected with peak sets using bedtools 2.24.0; 19 peaks were required to have a 50% overlap with the CNV region. Peak sets were determined based on the 20 presence of the peak in at least 5% of the cells for that cell type. The total number of peaks overlapping a CNV 21
were compared to the number of peaks that did not overlap with a CNV for each cell type. The merged peak set 22 was used as background and compared by Fisher's exact test. P-values were Bonferroni corrected for 27 tests 23 (# of cell types). 24 25
Cell type-specific GWAS enrichment testing 26
We in each of 27 cell type-specific peak sets, which we defined as peaks present in at least 1% of cells from a given 34 cell type. These associations were adjusted for the union of the peak sets as well as for 52 annotations from 
